By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glycotex Inc. 

140 Wicks Road

North Ryde  New South Wales  2113  Australia
Phone: 61-2-8877-6177 Fax: 61-2-9878-0055


Start Up

Company News
Glycotex Inc. Releases Final Phase II Clinical Trials Results in the Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 6/27/2011 7:59:51 AM
Glycotex Inc. Awarded Cash Grant Under the U.S. Government Qualifying Therapeutic Discovery Program 11/24/2010 6:48:02 AM
Glycotex Inc. Expands Patent Portfolio in Advanced Wound Healing Indications 2/11/2010 10:20:39 AM
Glycotex Inc.'s Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 4/7/2009 9:02:42 AM
Glycotex Inc. Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing 10/21/2008 8:45:21 AM
Glycotex Inc. Finalizes Collaboration Agreement with Advanced Medical Solutions Group plc (AMS) 10/17/2008 11:44:48 AM
Glycotex Inc. Completes Enrollment in Phase IIa Study of Lead Product Candidate GLYC-101 for Wound Healing 3/13/2008 8:26:11 AM
Glycotex Inc. Receives $0.5 Million From Second Tranche of Private Share Placement 1/16/2008 8:52:58 AM
Glycotex Inc. Obtains Active IND From US FDA for GLYC-101 Wound Healing Compound 1/8/2008 9:55:49 AM
Novogen Limited (NVGN) Subsidiary Glycotex Inc. Receives Additional Funding 2/27/2007 2:38:35 PM